DeepMed Research

JOHN HOPE FRANKLIN CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 5K

Market Cap: -

Website: http://www.duke.edu

Clinical Trials

Food is Medicine: Pilot Study

Not Applicable

Active, not recruiting

Conditions: Weight Loss

First Posted Date: 2025-01-28

Last Posted Date: 2025-05-18

Lead Sponsor: Duke University

Target Recruit Count: 43

Registration Number: NCT06797453

Locations: 🇺🇸
Duke University, Durham, North Carolina, United States

Rare Glycogen Storage Diseases Natural History Study

Recruiting

Conditions: GSD XIII
GSD XV
Glycogen Storage Disease
GSD Type 0A
GSD Type 0B
GSD VII
Tarui Disease
GSD X
GSD XII
Polyglucosan Body Myopathy 2

First Posted Date: 2025-01-27

Last Posted Date: 2025-01-28

Lead Sponsor: Duke University

Target Recruit Count: 200

Registration Number: NCT06795152

Locations: 🇺🇸
Duke University, Durham, North Carolina, United States

The Effect of Non-invasive Brain Stimulation rTMS on Hand Muscles in Chronic Stroke Patients.

Not Applicable

Not yet recruiting

Conditions: Stroke
Stroke Patients
Arm Weakness as a Consequence of Stroke
Brain Stimulation
Transcranial Magnetic Stimulation Repetitive
Transcranial Magnetic Stimulation
Motor Learning
Chronic Stroke Patients
Chronic Stroke Survivors

First Posted Date: 2025-01-09

Last Posted Date: 2025-02-26

Lead Sponsor: Duke University

Target Recruit Count: 26

Registration Number: NCT06765642

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Allopregnanolone in Post-Stroke Depression

Phase 2

Not yet recruiting

Conditions: Post Stroke Depression

Interventions: Drug: Zuranolone

First Posted Date: 2025-01-06

Last Posted Date: 2025-03-10

Lead Sponsor: Duke University

Target Recruit Count: 6

Registration Number: NCT06759558

Locations: 🇺🇸
Duke South Neurology Clinic 1L, Durham, North Carolina, United States

Genetic Testing to Understand and Address Renal Disease Disparities Across the United States Pharmacogenetic Substudy

Not Applicable

Completed

Conditions: Chronic Kidney Disease
Hypertension

First Posted Date: 2024-12-24

Last Posted Date: 2025-04-30

Lead Sponsor: Duke University

Target Recruit Count: 1874

Registration Number: NCT06748040

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
University of Florida - Gainesville, Gainesville, Florida, United States
🇺🇸
University of Florida - Jacksonville, Jacksonville, Florida, United States

and more 5 locations

Opioids, Low Nicotine Cigarettes, and Chronic Pain

Not Applicable

Recruiting

Conditions: Chronic Pain
Tobacco Use
Opioid Substitution Treatment

First Posted Date: 2024-12-24

Last Posted Date: 2025-05-16

Lead Sponsor: Duke University

Target Recruit Count: 60

Registration Number: NCT06747871

Locations: 🇺🇸
North Pavilion, Durham, North Carolina, United States

NASA Prebreathe Study

Phase 1

Recruiting

Conditions: Decompression Sickness

Interventions: Other: Altitude
Drug: 100% Oxygen

First Posted Date: 2024-12-18

Last Posted Date: 2025-05-14

Lead Sponsor: Duke University

Target Recruit Count: 12

Registration Number: NCT06740305

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Splanchnic X: Splanchnic Nerve Block in Heart Failure With Reduced Ejection Fraction

Not Applicable

Recruiting

Conditions: Heart Failure

First Posted Date: 2024-12-13

Last Posted Date: 2025-04-17

Lead Sponsor: Duke University

Target Recruit Count: 54

Registration Number: NCT06733012

Locations: 🇺🇸
Duke, Durham, North Carolina, United States

Resilience Reminders

Not Applicable

Not yet recruiting

Conditions: Cancer
Youth Cancer
Young Adult Cancer
Distress, Psychological

First Posted Date: 2024-12-13

Last Posted Date: 2025-05-18

Lead Sponsor: Duke University

Target Recruit Count: 40

Registration Number: NCT06732375

Locations: 🇺🇸
Duke Cancer Institute, Durham, North Carolina, United States

HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT

Early Phase 1

Not yet recruiting

Conditions: Hematologic Malignancy

Interventions: Drug: Abatacept

First Posted Date: 2024-12-12

Last Posted Date: 2024-12-20

Lead Sponsor: Duke University

Target Recruit Count: 10

Registration Number: NCT06731504

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy